Home » Newsletters » BioWorld Asia

BioWorld Asia

July 26, 2000

View Archived Issues

Bone Marrow Could Yield Cells To Repopulate All Cell Types

French Start-Up Innate Pharma Raises $4.5M For Cancer Work

Compugen Plans IPO On Nasdaq Following $35M Private Financing

Ardana Spins Out OF MRC To Focus On Women's Health

EuropaBio, EPPOSI Meeting Focused On Rare Diseases

Vernalis' Migraine Treatment Cleared For French Market

EU Minister Remain Cautious About GMO Authorizations

G8 Leaders Take Supportive Stance On Biotechnology

Personal Chemistry Seeks $20M After Patent Questions Sink IPO

GPC, Cytovia Collaborate On Reverse Genomics, Cell Assays

Teva Strengthens European Ties With $135M Financing

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...